The miR‐3127‐5p/p‐<scp>STAT</scp>3 axis up‐regulates <scp>PD</scp>‐L1 inducing chemoresistance in non‐small‐cell lung cancer

Dongfang Tang, Dandan Zhao, Yun Wu, +5

Journal of Cellular and Molecular Medicine

ImmunologyCancer BiologyTumor BiologyIncreased Pd-l1Autophagy +17

MiR‐200b expression in breast cancer: a prognostic marker and act on cell proliferation and apoptosis by targeting Sp1

Yasai Yao, Jian Hu, Zan Shen, +7

Journal of Cellular and Molecular Medicine

The tumor suppressor miR-124 inhibits cell proliferation by targeting STAT3 and functions as a prognostic marker for postoperative NSCLC patients

Xiumei Li, Zhuang Yu, Yong Li, +5

International Journal of Oncology

Prognostic MarkerMedicineHigh Stat3 ExpressionImmunologyPathology +12

P53 prevent tumor invasion and metastasis by down-regulating IDO in lung cancer

Dongfang Tang, Lu Yue, Ruyong Yao, +4

Oncotarget

<scp>FOXM</scp>1 mediates resistance to docetaxel in gastric cancer <i>via</i> up‐regulating Stathmin

Xiaoxiao Li, Ruyong Yao, Yue Lu, +5

Journal of Cellular and Molecular Medicine

PathologyCancer BiologyMicrotubule DynamicsTumor BiologyMolecular Pharmacology +16

Genetic Polymorphism of GSTP1: Prediction of Clinical Outcome to Oxaliplatin/5-FU-based Chemotherapy in Advanced Gastric Cancer

Qingfang Li, Ruyong Yao, Kewei Liu, +3

Journal of Korean Medical Science

Advanced Gastric CancerGeneticsGenetic EpidemiologyGastroenterologyPathology +15

The combination of ERCC1 and XRCC1 gene polymorphisms better predicts clinical outcome to oxaliplatin-based chemotherapy in metastatic colorectal cancer

Jun Liang, Tao Jiang, Ruyong Yao, +3

Cancer Chemotherapy and Pharmacology

Xrcc1 Gene PolymorphismsMedicineOxaliplatin-based ChemotherapyColorectal CancerPathology +6

CRM1 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas

Fang Zhou, Wensheng Qiu, Ruyong Yao, +5

Medical Oncology

Gastrointestinal OncologyMedicinePathologyCancer GenomicsPoor Prognosis +6

Forkhead box transcription factor 1 expression in gastric cancer: FOXM1 is a poor prognostic factor and mediates resistance to docetaxel

Xiaoxiao Li, Wensheng Qiu, Bin Liu, +4

Journal of Translational Medicine

microRNA expression profiles associated with survival, disease progression, and response to gefitinib in completely resected non-small-cell lung cancer with EGFR mutation

Yi Shen, Dongfang Tang, Ruyong Yao, +5

Medical Oncology

OncologyNon-small-cell Lung CancerMedicinePathologyCancer Genomics +9